Skip to content
Ion channel library
  • News
  • Resources
    • Drugs
    • Companies
    • Labs
    • Foundations
    • Classification
    • External
    • Software
  • Blog
    • Fundamentals
    • Analytics
    • Interviews
    • Insights
    • Bizarre
    • Quotes
  • Multimedia
    • Infographics
  • Events
Ion channel library
Ion channel library
  • News
  • Resources
    • Drugs
    • Companies
    • Labs
    • Foundations
    • Classification
    • External
    • Software
  • Blog
    • Fundamentals
    • Analytics
    • Interviews
    • Insights
    • Bizarre
    • Quotes
  • Multimedia
    • Infographics
  • Events

Artem Kondratskyi

traffic light
22/12/2020

FDA approves Vertex’s TRIKAFTA®, SYMDEKO® and KALYDECO® for use in people with cystic fibrosis with certain rare mutations

News
signing contract
22/12/2020

Ligand’s Icagen and GSK enter global collaboration and license agreement to target neurological disorders

News
Andrea Brüggemann
21/12/2020

Chief Scientific Officer at Nanion, Andrea Brüggemann, on automated patch clamp in academia, ion channel industry and fundraising

Interviews
virus
18/12/2020

Soricimed to investigate the potential benefit of its TRPV6 inhibitor, SOR-C13, in the treatment of COVID-19

News
deal
17/12/2020

Cadent Therapeutics and its ion channel programs to be acquired by Novartis

News
neurons
16/12/2020

Kineta initiates Phase 1 clinical trial of its nAChR antagonist, KCP506, for the treatment of chronic pain

News
antibody
15/12/2020

TetraGenetics announces discovery of functional antibodies against Nav1.8

News
neurons
12/12/2020

QurAlis’ selective KCNQ2/3 opener, QRA-244, demonstrates up to 20-fold increase in potency and dramatic reduction in side effects compared to retigabine

News
lysosomes
19/11/2020

Caraway Therapeutics receives research grant from the Michael J. Fox Foundation to further study the role of TMEM175 in Parkinson’s disease

News
Lesley Anson
10/11/2020

Former Nature editor Lesley Anson on publishing in high-profile journals and the future of scientific publishing

Interviews
tubes
07/11/2020

Saniona regains GABAa5 negative allosteric modulator program from Boehringer Ingelheim

News
Trophies
29/10/2020

Outstanding ion channel scientists receive honorary awards

News
Thomas Binzer
27/10/2020

VP R&D and Marketing at Sophion, Thomas Binzer, on automated patch clamp, marketing in science and building bridges with academia

Interviews
collaboration
26/10/2020

Metrion Biosciences and Grünenthal Group extended their ion channel drug discovery collaboration

News
building
15/10/2020

Daewoong Pharmaceutical spins off its ion channel R&D unit into a new company iN Therapeutics

News
lab
09/10/2020

Knopp Biosciences has entered the second year of the NIH-funded research to discover non-opioid treatments for chronic pain

News
contract
08/10/2020

Kineta and Genentech extended research collaboration to develop a first-in-class α9/α10 nAchR antagonist for the treatment of chronic pain

News
lungs
07/10/2020

Enterprise Therapeutics’ TMEM16A potentiator program acquired by Roche

News
pills
06/10/2020

NMD Pharma Announces First Subject Dosed in a Combined Phase I/IIa Clinical Trial of ClC-1 Channel Inhibitor, NMD670, for the Treatment of Symptoms of Myasthenia Gravis

News
cells
30/09/2020

selectION Secures $5M Promissory Note to advance its Kv1.3-selective peptide blocker into clinical development

News
handshake
28/09/2020

Sophion Bioscience Strengthens its Team by appointing Damian Bell as Director of Scientific Affairs

News
pain
22/09/2020

Algiax Pharmaceuticals has begun enrolling patients in a Phase IIa Proof-of-Concept Study evaluating GABAA receptor modulator, AP-325, in Chronic Neuropathic Pain

News
Chris Mathes
15/09/2020

Chief Commercial Officer at AnaBios, Chris Mathes, on his career, the automated patch clamp race and experiments with human cells

Interviews
autophagy
11/09/2020

Casma Therapeutics has raised $50 Million to advance its TRPML1 agonist for the treatment of muscular dystrophy

News
depression
03/09/2020

VistaGen announces positive results from second preclinical study of AV-101, an NMDAR antagonist, in combination with probenecid

News
mask
02/09/2020

Nocion Therapeutics initiated a Phase 1 clinical trial of its novel small molecule charged sodium channel blocker for the treatment of cough

News
FredrikElinder
01/09/2020

Professor Fredrik Elinder on ion channels in Sweden, the new open-access journal Physiologica and ultramarathons

Interviews
signing contract
26/08/2020

ACADIA Pharmaceuticals acquires CerSci Therapeutics

News
lungs
17/08/2020

Enterprise Therapeutics initiates a Phase I study of its novel TMEM16A potentiator, ETD002, for the treatment of cystic fibrosis

News
neurons
12/08/2020

Kineta is about to initiate Phase 1 clinical trials of its α9α10 nAChR antagonist KCP506 for the treatment of chronic neuropathic pain

News
artificial-neural-network
28/07/2020

Praxis has raised another $110M to advance its ion channel drugs

News
handshake
21/07/2020

CalciMedica collaborating with EpiPharma on CRAC channel inhibitor drugs

News
pepper
21/07/2020

FDA approved QUTENZA® (capsaicin) patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet

News
coronavirus
16/07/2020

CalciMedica’s CRAC inhibitor Auxora™ shows promise as a treatment for severe COVID-19 pneumonia

News
stethoscope
14/07/2020

NMD Pharma is about to start a combined Phase I/IIa clinical trial with its ClC-1 channel inhibitor in healthy subjects and patients with myasthenia gravis

News
doctor
06/07/2020

BELLUS Health reports topline results from its Phase 2 trial of BLU-5937, a P2X3 antagonist, for the treatment of chronic cough

News
crowd
01/07/2020

Is crowdfunding an option to finance your research?

Insights
kidney
30/06/2020

Goldfinch Bio has raised $100 Million to support the advancement of its TRPC5 inhibitor and cannabinoid receptor 1 inverse agonist for the treatment of kidney diseases

News
Lucie Delemotte
23/06/2020

Computational biophysicist Lucie Delemotte on ion channel simulations, coronavirus and kickboxing

Interviews
neurons in the brain
18/06/2020

Engrail Therapeutics Raises $32 Million in Series A Financing to develop neuroscience therapeutics

News
Andrea Meredith
09/06/2020

Maryland professor Andrea Meredith on BK channelopathies, her KCNMA1 foundation and patching on sewing machines

Interviews
pipe
03/06/2020

What is a channel?

Bizarre
signing contract
29/05/2020

Ligand expanded Icagen’s collaboration with Roche to develop ion channel modulators for the treatment of neurological disorders

News
ion road sign
28/05/2020

What is an ion?

Bizarre
Ardem Patapoutian and David Julius
27/05/2020

Ardem Patapoutian and David Julius have won the 2020 Kavli Prize in Neuroscience “for their transformative discovery of receptors for temperature and pressure.”

News
coronavirus
22/05/2020

CalciMedica Raises $15 Million to support ongoing clinical trials in patients with COVID-19 pneumonia

News
dna
20/05/2020

CODA Biotherapeutics collaborates with the Facial Pain Research Foundation to develop treatments for neuropathic pain

News
Damian Bell
13/05/2020

Head of Electrophysiology at IONTAS, Damian Bell, on ion channel antibodies, automated patch clamp and his obsession with ion channels

Interviews
network
04/05/2020

Praxis has raised over $100 Million to advance its ion channel modulators for the treatment of neurological disorders

News
system
04/05/2020

Autifony Therapeutics initiates a Phase I study of its novel Kv3 modulator for schizophrenia and hearing disorders

News
Hugues Abriel
20/04/2020

Professor Hugues Abriel on ion channels in Switzerland, crowdfunding, and ethical aspects of science

Interviews
hand shaking
26/03/2020

Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia

News
redpin therapeutics
25/03/2020

Redpin Therapeutics has raised $15.5M to advance the development of its ion channel-based chemogenetics platform

News
merck-gefapixant-p2x3
17/03/2020

Merck announces positive results from Phase 3 trials evaluating Gefapixant, a P2X3 receptor antagonist, for the treatment of chronic cough

News
hand
10/03/2020

Asana BioSciences announces positive results from Phase 1b trials evaluating their sodium channel blocker, ASN008, for the treatment of pruritus in atopic dermatitis

News
numbers
06/03/2020

Trends in ion channel paper authorship

Analytics
ion channel scientists
25/02/2020

How many ion channel scientists are there?

Analytics
signing contract
14/02/2020

Ligand Pharmaceuticals will acquire core assets, partnered programs and ion channel technologies from Icagen

News
journals
08/02/2020

TOP ion channel-friendly journals

Analytics
neurones
07/02/2020

CODA Biotherapeutics acquires Attenua and three clinical stage assets

News
thumbs up/down
01/02/2020

Vertex has discontinued Phase 1 development of its NaV1.8 inhibitor VX-961

News
journal_trends_featured
31/01/2020

Ion channel journal trends

Analytics
clinical trial
25/01/2020

Cadent Therapeutics announced that FDA accepted its IND application for SK channel modulator for the treatment of spinocerebellar ataxia

News
library
20/01/2020

WHO, WHAT and WHY of ionchannellibrary

News
electrical signals
16/01/2020

Electrical Signals

Infographics
tulips
15/01/2020

Extraordinary ordinary patch-clamp

Fundamentals
highway with cars
14/01/2020

Membrane transport

Fundamentals
Galvani experiment
13/01/2020

History of ion channels

Fundamentals
membrane transport
13/01/2020

Membrane Transport

Infographics
lipid membrane permeability
13/01/2020

Permeability of Lipid Bilayers

Infographics
Post navigation
Older posts
Page1 Page2 Next →

ionchannellibrary

Ionchannellibrary is a digital media resource on ion channels. If you care about ion channels, then Ionchannellibrary is for you!

about

Why does ionchannellibrary exist?
Who is Artem?

get in touch

[email protected]

follow

LinkedIn
Twitter
© 2021 Artem Kondratskyi   |   Terms of Use   |   Privacy Policy